CN1039999C - 后叶加压素拮抗物和催产素拮抗物其制备方法和含有它们的药物 - Google Patents
后叶加压素拮抗物和催产素拮抗物其制备方法和含有它们的药物 Download PDFInfo
- Publication number
- CN1039999C CN1039999C CN93119219A CN93119219A CN1039999C CN 1039999 C CN1039999 C CN 1039999C CN 93119219 A CN93119219 A CN 93119219A CN 93119219 A CN93119219 A CN 93119219A CN 1039999 C CN1039999 C CN 1039999C
- Authority
- CN
- China
- Prior art keywords
- substitution
- alkyl group
- low alkyl
- group
- lower alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Electric Connection Of Electric Components To Printed Circuits (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP27758992 | 1992-10-16 | ||
| JP277589/92 | 1992-10-16 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB971231559A Division CN1306935C (zh) | 1992-10-16 | 1993-10-16 | 后叶加压素拮抗物和催产素拮抗物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1098716A CN1098716A (zh) | 1995-02-15 |
| CN1039999C true CN1039999C (zh) | 1998-09-30 |
Family
ID=17585569
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN93119219A Expired - Lifetime CN1039999C (zh) | 1992-10-16 | 1993-10-16 | 后叶加压素拮抗物和催产素拮抗物其制备方法和含有它们的药物 |
| CNB971231559A Expired - Lifetime CN1306935C (zh) | 1992-10-16 | 1993-10-16 | 后叶加压素拮抗物和催产素拮抗物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB971231559A Expired - Lifetime CN1306935C (zh) | 1992-10-16 | 1993-10-16 | 后叶加压素拮抗物和催产素拮抗物 |
Country Status (13)
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW270927B (US07229986-20070612-C00147.png) * | 1992-10-16 | 1996-02-21 | Otsuka Pharma Co Ltd | |
| US5869499A (en) * | 1993-07-15 | 1999-02-09 | Pfizer Inc | Benzyloxyquinuclidines as substance P antagonists |
| DE69535486T2 (de) * | 1994-06-15 | 2008-04-10 | Otsuka Pharmaceutical Co., Ltd. | Benzoheterocyclische Verbindungen verwendbar als Vasopressin- oder Oxytocin-Modulatoren |
| US5696112A (en) * | 1995-01-17 | 1997-12-09 | American Cyanamid Company | Fused heterocyclic azepines as vasopressin antagonists |
| TW359669B (en) * | 1995-12-15 | 1999-06-01 | Otsuka Pharma Co Ltd | Benzazepine derivatives |
| US6268359B1 (en) | 1998-01-28 | 2001-07-31 | Senju Pharmaceutical Co., Ltd. | Preventives or remedies for vision disorders |
| CA2326117A1 (en) * | 1998-03-27 | 1999-10-07 | Oregon Health Sciences University | Vitamin d and its analogs in the treatment of tumors and other hyperproliferative disorders |
| GB2355454A (en) * | 1999-10-20 | 2001-04-25 | Ferring Bv | Antidiuretic agents |
| GB0000079D0 (en) * | 2000-01-05 | 2000-02-23 | Ferring Bv | Novel antidiuretic agents |
| WO2001087834A1 (fr) * | 2000-05-16 | 2001-11-22 | Takeda Chemical Industries, Ltd. | Antagoniste de l'hormone de concentration de la melanine |
| US6977254B2 (en) * | 2001-04-12 | 2005-12-20 | Wyeth | Hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
| US7022699B2 (en) | 2001-04-12 | 2006-04-04 | Wyeth | Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators |
| US7202239B2 (en) * | 2001-04-12 | 2007-04-10 | Wyeth | Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists |
| US7064120B2 (en) * | 2001-04-12 | 2006-06-20 | Wyeth | Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
| US7109193B2 (en) | 2001-04-12 | 2006-09-19 | Wyeth | Tricyclic diazepines tocolytic oxytocin receptor antagonists |
| US7326700B2 (en) * | 2001-04-12 | 2008-02-05 | Wyeth | Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
| US6900200B2 (en) | 2001-04-12 | 2005-05-31 | Wyeth | Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
| CA2445348A1 (en) | 2001-04-27 | 2002-11-07 | Mitsubishi Pharma Corporation | Novel benzylpiperidine compound |
| AU2002342045C1 (en) * | 2001-10-12 | 2009-07-30 | Azevan Pharmaceuticals, Inc. | Beta-lactamyl vasopressin Vla antagonists |
| BR0214224A (pt) | 2001-11-16 | 2004-09-21 | Yamanouchi Pharma Co Ltd | Derivado de 4,4-diflúor-1,2,3,4-tetrahidro-5h-1-benzazepina ou sal do mesmo |
| CN1863778A (zh) * | 2003-10-08 | 2006-11-15 | 伊莱利利公司 | 用于治疗血脂异常的化合物及方法 |
| TWI459947B (zh) * | 2007-06-26 | 2014-11-11 | Otsuka Pharma Co Ltd | 苯并氮呯化合物及藥學製劑 |
| CN102030709B (zh) * | 2009-09-25 | 2013-10-16 | 江苏豪森医药集团有限公司 | 用作加压素受体拮抗剂的苯并氮杂卓类化合物 |
| CA3036245C (en) * | 2016-09-13 | 2021-07-20 | Arbutus Biopharma Corporation | Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same |
| WO2019003433A1 (ja) | 2017-06-30 | 2019-01-03 | 大塚製薬株式会社 | ベンゾアゼピン誘導体 |
| CN112851583B (zh) * | 2021-01-19 | 2023-09-08 | 徐州医科大学 | 新型苯并氮杂䓬类化合物、组合物及其用途 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991005549A1 (en) * | 1989-10-20 | 1991-05-02 | Otsuka Pharmaceutical Co., Ltd. | Benzoheterocyclic compounds |
| CN1066653A (zh) * | 1991-04-19 | 1992-12-02 | 大制药株式会社 | 苯并杂环化合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3516987A (en) * | 1966-04-25 | 1970-06-23 | American Home Prod | 1-methylsulfonyl-7-methoxy-2,3,4,5-tetrahydro-1h-1-benzazepine |
| US3542760A (en) * | 1966-04-25 | 1970-11-24 | American Home Prod | 7-alkoxy-2,3,4,5-tetrahydro-1h-1-benzazepine and derivatives thereof |
| US5258510A (en) * | 1989-10-20 | 1993-11-02 | Otsuka Pharma Co Ltd | Benzoheterocyclic compounds |
| JP2905909B2 (ja) * | 1991-04-19 | 1999-06-14 | 大塚製薬株式会社 | バソプレシン拮抗剤 |
| TW270927B (US07229986-20070612-C00147.png) * | 1992-10-16 | 1996-02-21 | Otsuka Pharma Co Ltd |
-
1993
- 1993-10-14 TW TW082108510A patent/TW270927B/zh not_active IP Right Cessation
- 1993-10-15 ES ES93922637T patent/ES2300101T3/es not_active Expired - Lifetime
- 1993-10-15 AT AT93922637T patent/ATE383861T1/de active
- 1993-10-15 WO PCT/JP1993/001483 patent/WO1994008582A1/ja active IP Right Grant
- 1993-10-15 CA CA002124696A patent/CA2124696C/en not_active Expired - Lifetime
- 1993-10-15 US US08/244,424 patent/US5622947A/en not_active Expired - Lifetime
- 1993-10-15 AU AU51614/93A patent/AU663628B2/en not_active Expired
- 1993-10-15 MX MX9306425A patent/MX9306425A/es active IP Right Grant
- 1993-10-15 EP EP07021546A patent/EP1902717A3/en not_active Withdrawn
- 1993-10-15 EP EP93922637A patent/EP0620003B1/en not_active Expired - Lifetime
- 1993-10-15 DE DE69334199T patent/DE69334199T2/de not_active Expired - Lifetime
- 1993-10-15 DK DK93922637T patent/DK0620003T3/da active
- 1993-10-15 KR KR1019940702053A patent/KR100291816B1/ko not_active IP Right Cessation
- 1993-10-16 CN CN93119219A patent/CN1039999C/zh not_active Expired - Lifetime
- 1993-10-16 CN CNB971231559A patent/CN1306935C/zh not_active Expired - Lifetime
-
1996
- 1996-10-15 US US08/732,595 patent/US5753644A/en not_active Expired - Lifetime
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991005549A1 (en) * | 1989-10-20 | 1991-05-02 | Otsuka Pharmaceutical Co., Ltd. | Benzoheterocyclic compounds |
| CN1066653A (zh) * | 1991-04-19 | 1992-12-02 | 大制药株式会社 | 苯并杂环化合物 |
Also Published As
| Publication number | Publication date |
|---|---|
| AU5161493A (en) | 1994-05-09 |
| EP0620003A1 (en) | 1994-10-19 |
| EP1902717A3 (en) | 2008-08-06 |
| DK0620003T3 (da) | 2008-05-26 |
| EP0620003B1 (en) | 2008-01-16 |
| AU663628B2 (en) | 1995-10-12 |
| CA2124696C (en) | 2005-01-04 |
| EP1902717A2 (en) | 2008-03-26 |
| US5753644A (en) | 1998-05-19 |
| KR100291816B1 (ko) | 2001-10-24 |
| MX9306425A (es) | 1994-05-31 |
| DE69334199T2 (de) | 2009-01-15 |
| CN1183277A (zh) | 1998-06-03 |
| ES2300101T3 (es) | 2008-06-01 |
| WO1994008582A1 (en) | 1994-04-28 |
| CA2124696A1 (en) | 1994-04-28 |
| US5622947A (en) | 1997-04-22 |
| TW270927B (US07229986-20070612-C00147.png) | 1996-02-21 |
| EP0620003A4 (en) | 1995-02-15 |
| ATE383861T1 (de) | 2008-02-15 |
| DE69334199D1 (de) | 2008-03-06 |
| CN1306935C (zh) | 2007-03-28 |
| CN1098716A (zh) | 1995-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1039999C (zh) | 后叶加压素拮抗物和催产素拮抗物其制备方法和含有它们的药物 | |
| CN1035670C (zh) | 一种制备苯并杂环化合物或其盐的方法 | |
| CN1036394C (zh) | 喹诺酮衍生物的制备方法 | |
| CN1230431C (zh) | 用作类胰蛋白酶抑制剂的芳基甲胺衍生物 | |
| CN1104418C (zh) | 苯并杂环衍生物 | |
| CN1256326C (zh) | 治疗心脏和肾功能不全的新型4－(氧烷氧基苯基)－3－氧哌啶化合物 | |
| CN1048484C (zh) | 含苯并杂环化合物的药物组合物的制备方法 | |
| CN1051548C (zh) | 杂双环衍生物、含有它们的药物组合物及其制备方法与用途 | |
| CN1058710C (zh) | 苯甲酰胺衍生物及其制法、用途和含其的药物组合物 | |
| CN1097051C (zh) | N－杂芳基吡啶磺酰胺衍生物及其作为内皮素拮抗剂的用途 | |
| CN1062865C (zh) | 脒基苯并呋喃衍生物和脒基苯并噻吩衍生物以及它们的盐的制备方法 | |
| CN1204121C (zh) | 1,4－取代环胺衍生物或二氢吲哚衍生物及其药物 | |
| EP1716135B1 (en) | Piperidinylcarbonyl-pyrrolidines and their use as melanocortin agonists | |
| CN1646495A (zh) | 胺化合物及其用途 | |
| CN1993339A (zh) | 芳香化合物 | |
| CN1255401C (zh) | 芳基－哌嗪衍生物、及其制备和作为速激肽拮抗剂的应用 | |
| CN1209125A (zh) | 作为速激肽拮抗剂的哌嗪类衍生物 | |
| CN1192729A (zh) | 苯甲酰胺衍生物和它们作为后叶加压素拮抗剂的应用 | |
| CN1067075C (zh) | 作为中性白细胞弹性蛋白酶抑制剂的吡咯并吡咯酮 | |
| CN1950343A (zh) | 胺系碱性化合物及其用途 | |
| CN1390201A (zh) | 作为ccr5拮抗剂的环胺化合物 | |
| CN1514828A (zh) | 治疗hiv的吡唑衍生物 | |
| CN1856475A (zh) | 异喹啉钾通道抑制剂 | |
| CN1041919C (zh) | 用作血小板激活因子拮抗物的N-(3-哌啶基碳酰)-β-氨基丙酸衍生物 | |
| CN1098264C (zh) | 用于治疗变态反应疾病的取代的4－(1h－苯并咪唑－2－基－氨基)哌啶 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CX01 | Expiry of patent term |
Expiration termination date: 20131016 Granted publication date: 19980930 |